Free Trial

AEON Biopharma (AEON) Institutional Ownership

AEON Biopharma logo
$0.94 -0.01 (-1.05%)
Closing price 03:57 PM Eastern
Extended Trading
$0.94 +0.01 (+0.53%)
As of 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for AEON Biopharma (NASDAQ:AEON)

Current
Institutional Ownership
Percentage
22.78%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$653.11K
Number of
Institutional Sellers
(last 12 months)
0
Get AEON Insider Trade Alerts

Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AEON Institutional Buying and Selling by Quarter

AEON Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026XTX Topco Ltd56,852$63K0.0%+251.8%0.480%
2/9/2026Geode Capital Management LLC60,134$66K0.0%+27.7%0.508%
5/7/2025Dauntless Investment Group LLC1,025,000$594K0.7%N/A9.731%
2/25/2025Polar Asset Management Partners Inc.2,762,688$1.49M0.0%-23.3%3.455%
2/19/2025Formidable Asset Management LLC689,182$372K0.1%+76.8%0.862%
2/17/2025Polar Asset Management Partners Inc.2,762,688$1.49M0.0%-23.3%3.455%
2/14/2025Blue Owl Capital Holdings LP3,049,361$1.65M0.4%-8.7%3.813%
11/16/2024Geode Capital Management LLC243,168$255K0.0%+30.1%0.622%
11/15/2024Polar Asset Management Partners Inc.3,599,918$3.78M0.1%-2.0%9.202%
11/15/2024HighTower Advisors LLC23,776$25K0.0%N/A0.061%
11/7/2024Caprock Group LLC62,686$66K0.0%N/A0.160%
8/14/2024Davidson Kempner Capital Management LP90,053$95K0.0%-75.4%0.230%
5/17/2024Shaolin Capital Management LLC21,380$248K0.0%-97.7%0.057%
5/10/2024Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008%
2/7/2024Formidable Asset Management LLC58,193$419K0.1%-9.5%0.157%
11/9/2023Formidable Asset Management LLC64,311$360K0.1%N/A0.723%
11/6/2023Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283%


AEON Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AEON shares?

During the previous two years, 11 institutional investors and hedge funds held shares of AEON Biopharma. The most heavily invested institutionals were Vanguard Group Inc. ($8.80M), Blue Owl Capital Holdings LP ($1.65M), Polar Asset Management Partners Inc. ($1.49M), Dauntless Investment Group LLC ($594K), Formidable Asset Management LLC ($372K), Shaolin Capital Management LLC ($248K), and Davidson Kempner Capital Management LP ($95K).Learn more on AEON Biopharma's institutional investors.

What percentage of AEON Biopharma's stock is owned by institutional investors?

22.78% of AEON Biopharma's stock is owned by institutional investors. Learn more on AEON's institutional investor holdings.

Which institutional investors have been buying AEON Biopharma's stock?

The following institutional investors have purchased AEON Biopharma's stock in the last 24 months: Dauntless Investment Group LLC ($1.03M), Vanguard Group Inc. ($549.21K), Formidable Asset Management LLC ($299.40K), Geode Capital Management LLC ($69.37K), Caprock Group LLC ($62.69K), XTX Topco Ltd ($40.69K), and HighTower Advisors LLC ($23.78K).

How much institutional buying is happening at AEON Biopharma?

Institutional investors have bought a total of 1,078,751 shares in the last 24 months. This purchase volume represents approximately $653.11K in transactions.



This page (NASDAQ:AEON) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners